Brian Rini

MD, Vanderbilt Health, US

Specializes in [Genitourinary Oncology]

• Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Professor of Medicine at Vanderbilt University
• Led numerous phase 3 clinical trials for renal cell carcinoma (RCC) that resulted in FDA approvals, published over 300 articles in top journals
• Founder https://www.uromigos.org

tosprivacy